Back to ITN Home

Overview and Mission
News and Press
Research Supported
Allergy / Asthma
Autoimmune Diseases
Islet Transplantation
Solid Organ Transplantation
Tolerance Assay Studies
Core Facilities
All Clinical Trials
All ITN Publications


Clinical Trials Seeking Patients

Contact Information
Solid OrganTransplantation Research
| Public Access Site for Researchers |
Solid Organ Transplantation Publications

MANUSCRIPTS

Bunde T, Kirchner A, Hoffmeister B, Habedank D, Hetzer R, Cherepnev G, Proesch S, Reinke P, Volk H-D, Lehmkuhl H, Kern F. Protection from cytomegalovirus after transplantation is orrelated with immediate early 1–specific CD8 T cells. J Exp Med 201: 1031–1036, 2005. [PubMed] [Reprint]

Fudaba,Y., Spitzer,T.R., Shaffer,J., Kawai,T., Fehr,T.I., Delmonico,F., Preffer,F., Tolkoff-Rubin,N., Dey,B., Saidman,S.L., Kraus,A., Bonnefoix,T., McAfee,S., Kattleman,K., Colvin,R.B., Sachs,D.H., Cosimi,A.B., and Sykes,M. (2006): Myeloma responses and tolerance following combined kidney and non-myeloablative marrow transplantation: in vivo and in vitro analyses.  Am J Transplant 6: 2121-2133, 2006. [PubMed] [Reprint]

Hernandez-Fuentes MP, Lechler RI. Chronic graft loss: Immunological and non-immunological factors. In "Kidney Transplantation: Strategies to Prevent Organ Rejection. Ronco C., Chiaramonte S., Remuzzi G (eds). Contrib Nephrol, Basel , Karger, 146: 54-64, 2005. [PubMed]

Kawai, T, Cosimi AB, Spitzer TR, Tolkoff-Rubin, N, Suthanthiran M, Saidman SL, Shaffer J, Preffer FI, Ding R, Sharma V, Fishman JA, Dey B, Ko DSC, Hertl M, Goes NB, Wong W, Williams WW, Colvin RB, Sykes M, Sachs DH. HLA-Mismatched renal transplantation without maintenance immunosuppression. N Engl J Med 358: 353-61, 2008 [PubMed] [Reprint]

Matthews JB, Ramos E, Bluestone JA. Clinical trials of transplant tolerance: slow but steady progress. Am J Transplant 3:794-803, 2003. [PubMed] [Reprint]

Mazariegos GV, Zahorchak AF, Reyes J, Ostrowski L, Flynn B, Zeevi A, Thomson AW. Dendritic cell subset ratio in peripheral blood correlates with successful withdrawal of immunosuppression in liver transplant patients. Am J Transplant 3:689-96, 2003. [Abstract] [$Full Text$]

Thomson AW, Mazariegos GV, Reyes J, Donnenberg VS, Donnenberg AD, Bentlejewski C, Zahorchak AF, O'Connell PJ, Fung JJ, Jankowska-Gan E, Burlingham WJ, Heeger PS, Zeevi A. Monitoring the patient off immunosuppression: Conceptual framework for a proposed tolerance assay study in liver transplant recipients. Transplantation 72:S13-22, 2001. [PubMed]

Bluestone JA, Matthews JB, Krensky AM. The immune tolerance network: the "Holy Grail" comes to the clinic. J Am Soc Nephrol 11:2141-6, 2000. [Full Text] [Reprint]

Abstracts 

Kawai T, Sachs DH, Spitzer T, Sykes M, Tolkoff-Rubin N, Delmonico F, Saidman S, Shaffer J, Dey B, McAfee S, Williams W, Ko D, Hertl M, Goes N, Wong W, Colvin RB, Cosimi AB. Combined kidney and bone marrow transplantation for induction of mixed chimerism and renal allograft tolerance in HLA mismatched transplantation. [Abstract 1217] American Transplant Congress, Boston, MA, May 14-19, 2004. [Abstract]

Shaffer JM, Kawai T, Fudaba Y, Cosimi AB, Saidman S, Preffer F, Dombkowski D, Delmonico F, McAfee S, Rubin-Tolkoff N, Dey B, Spitzer TR, Sachs DH, Sykes M. Mechanisms of donor-specific unresponsiveness in tolerant recipient of combined non-myeloablative HLA-mismatched bone marrow and kidney transplantation. [Abstract 526] American Transplant Congress, Boston, MA, May 14-19, 2004. [Abstract]

Mazariegos GV, Zahorchak A, Reyes J, Chapman H, Girnita A, McDade K, Zeevi A, Thompson A. Immunologic Assays in Patients Successfully Withdrawn from Immunosuppression (IS) after Liver Transplantation. [Abstract 521] American Transplant Congress, Boston, MA, May 14-19, 2004. [Abstract]

Mazariegos GV, Zahorchak A, Zeevi A, Flynn B, Logar AJ, Reyes J, Thomson A. Dendritic cell subsets in peripheral blood of patients successfully withdrawn from immunosuppression after liver transplantation (LTx). [Abstract 644] American Transplant Congress, Washington DC, May30 - Jun 4, 2003. [Abstract]

Fudaba Y, Shaffer JM, Kraus A, Cosimi AB, Delmonico FL, Dey B, Kawai T, McAfee S, Preffer F, Tolkoff-Rubin N, Sachs DH, Saidman SL, Spitzer TR, Sykes M. Alloresponses in tolerant recipients of combined kidney/bone marrow transplantation with non-myeloablative conditioning. [Abstract 640] American Transplant Congress, Washington, DC, May 30-June 4, 2003. [Abstract]

Sykes, M. Mixed chimerism: from bench to bedside [Plenary Lecture - Abstract 0631] XIX Int'l Congress Transplantation, Miami, FL, Aug 25-30, 2002. [Abstract]

Mazariegos G, Zeevi A, Zahorchuk AF, Ostrowski L, Flynn B, Logar AJ, Dvorchik I, Reyes J, Thomson AW. Myeloid pDC1 is decreased as compared to plasmacytoid pDC2 lineage in peripheral blood of patients successfully withdrawn from immunosuppression after liver transplantation [Abstract 65] XIX Int'l Congress Transplantation, Miami, FL, Aug 25-30, 2002. [Abstract]

Wood K. Towards clinical tolerance: Regulatory Mechanisms. [Plenary Lecture] XIX Int'l Congress Transplantation, Miami, FL, Aug 25-30, 2002. [Abstract]

Seyfert-Margolis V, Implication of genomics and proteonics for transplantation. [Plenary Lecture] XIX Int'l Congress Transplantation, Miami, FL, Aug 25-30, 2002.

Heeger PS, Gebrauer B, Schulak JA, Tary-Lehmann M, Greenspan N, Hricik DE. Post transplant immune monitoring by elispot reveals differences between patients with and without acute rejection [Abstract 1067] American Transplant Congress, Washington DC, Apr 25 - May 1, 2002.


HomeTerms | © 2002-5 Immune Tolerance Network | Sponsors: NIAID, NIDDK and JDRF | Search